期刊文献+

肢体恶性黑色素瘤的肢体隔离热灌注化疗 被引量:8

Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities
原文传递
导出
摘要 目的探讨肢体隔离热灌注化疗术在肢体恶性黑色素瘤中的治疗效果。方法对41例肢体恶性黑色素瘤患者行肢体隔离热灌注化疗术,术后14~21d对有原发病灶的24例患者行原发病灶切除术,术后病理学检查评价肿瘤坏死情况。结果41例患者中,随访40例,失访1例,随访时间为6—113个月,无一例患者出现局部复发。全组患者的3年和5年生存率分别为95.0%和70.0%。灌注后,肿瘤平均缩小55.6%,术后病理学检查肿瘤坏死率为90%~100%者21例(87.5%),60%-89%者3例(12.5%)。结论肢体隔离热灌注化疗术是治疗肢体恶性黑色素瘤的有效方法,能显著降低局部复发率,提高长期生存率,改善患者的预后。 Objective To investigate the effect of isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities. Methods Limb isolated hyperthermic perfusion chemotherapy was performed in 41 patients with malignant melanoma of the extremities, and then the primary lesions in 24 patients were removed at 14-21 days after chemotherapy. Tumor necrosis was examined by pathology. Results Among the 41 patients, 40 cases were followed up for 6-113 months, and one was lost. There was no local recurrence in those patients. 29 cases were followed up for more than 3 years, and 26 of them were surviving. Forteen cases were followed up for more than five years, among them 9 cases were surviving. The 3-year and 5-year survival rates of the whole group were 95.0% and 70.0%, respectively. The average reduction of the tumor volume was 55.6% after perfusion. The pathological examination showed that tumor necrosis was 90% -100% ( complete response) in 21 cases ( 87.5% ) and 60% -89% ( partial response) in 3 cases ( 12.5% ). Conclusions The isolated limb hyperthermic perfusion chemotherapy is an effective treatment of limb malignant melanoma. It can significantly reduce the local recurrence rate, and improve the 5-year survival rate, prognosis and the quality of life of the patients.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第12期937-939,共3页 Chinese Journal of Oncology
关键词 黑色素瘤 四肢 热灌注 药物疗法 预后 Melanoma Extremities Perfusion Drug therapy Prognosis
  • 引文网络
  • 相关文献

参考文献10

  • 1Sato T, Sawaji Y, Matsui N, et al. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Biochem Biophys Res Commun, 1999, 265:189-193.
  • 2Sanki A, Kam PC, Thompson JF, et al. Long-term results of hyperthermic, isolated limb perfusion for melanoma : a reflection of tumor biology. Ann Surg, 2007, 245:591-596.
  • 3Noorda AM, Takkenberg B, Vrouenraets BC, et al. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma. Ann Surg Oncol, 2004, 11:491-499.
  • 4Kapma MR, Vrouenraets BC, Nieweg OE, et al. Major amputation for intractable extremity melanoma after failure of isolated limb perfusion. Eur J Surg Oncol, 2005, 31:95-99.
  • 5Koops HS, Carbe C, Hohenberger P. Is isolated limb perfusion of metastatic malignant melanoma of the extremity worthwhile? Eur J Cancer, 1996, 32 : 1633-1640.
  • 6Krementz ET, Carter RD, Sutherland CM, et al. Regional chemotherapy for melanonxa: a 35 year experience. Ann Surg, 1994, 220:520- 535.
  • 7Krementz ET, Sutherland CM, Muchmore JH. Isolated hyperthermia chemotherapy perfusion for limb melanoma. Surg Clin North Am, 1996, 76 : 1313-1330.
  • 8Klasse JM, Kroon BBR, van Geel AN, et al. Limb recurrence- free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coil Surg, 1994, 178:564-572.
  • 9Grtinhagen D J, Brunstein F, Graveland WJ, et al. One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases. Ann Surg, 2004, 240:939-948.
  • 10宋建民,李晶,韩飞容,付来华.改进隔离热灌注化疗技术治疗肢体恶性肿瘤[J].中国肿瘤临床,2010,37(24):1418-1420. 被引量:6

二级参考文献9

  • 1徐世伟,陈芳,赵玉华.下肢骨肉瘤区域高温隔离灌注化疗方法学的探讨[J].中华肿瘤杂志,1994,16(4):310-313. 被引量:9
  • 2夏贤良,杨迪生,范顺武,黄宗坚,许文根,徐少文,陶惠民,何荣新.下肢骨肉瘤高温隔离灌注化疗初步报告[J].中华骨科杂志,1994,14(11):645-648. 被引量:26
  • 3杨蕴,宋金钢,张瑾,张允祥.热或热药区域灌注治疗下肢恶性黑色素瘤(附5例报告)[J].中国肿瘤临床,1995,22(12):846-848. 被引量:1
  • 4Creech OJ Jr,Kremcntz ET,Ryan RF,et al.Chemotherapy of cancer:regional perfusion utilizing an extracorporeal drcuit[J].Ann Surg,1958,148(4):616-632.
  • 5Eggermont AM,Schraffordt Koops H,Lienard D,et al.Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas:a multicenter trial[[].J Clin Oncol,1996,14(10):2653-2665.
  • 6Lienard D,Ewalenko P,Delmotte JJ,et al.High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma[J].J Clin Oncol,1992,10(1):52-60.
  • 7Hohenberger P,Kettelhack C,Hermann A,et al.Functional outcome after preoperative isolated limb perfusion with rhtnfalpha/mel-phalan for high-grade extremity sarcoma[J].Eur J Cancer,2001,37:s34-s35.
  • 8Ponte P,Moniz JV,Farricha V,et al.Merkel cell carcinoma:an unusual indication for isolated limb perfusion[J].Dermatol Online J.2008,14(7):6.
  • 9杨迪生,范顺武,陶惠民,何荣新,叶招明,徐世伟,陈芳,黄宗坚.高温隔离灌注化疗在下肢骨与软组织肉瘤保肢治疗中的价值与限度[J].中国矫形外科杂志,1997,4(5):347-349. 被引量:13

共引文献5

同被引文献18

引证文献8

二级引证文献23

;
使用帮助 返回顶部